Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and Oxygen Strategies in COVID-19 ICU Patients
NCT04344730Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in coronavirus disease 2019 (COVID-19), acute hypoxemic respiratory failure (AHRF), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT04344730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04344730.